Work

Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy – Authors' reply

Year: 2022

Type: letter

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(22)00299-6

Authors: Thierry André, Luis A Diaz, Kai-Keen Shiu

Institutions: Inserm, Sorbonne Université, Centre de Recherche Saint-Antoine, Memorial Sloan Kettering Cancer Center, University College London Hospitals NHS Foundation Trust, University College London

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281962985

Cites: 3

Cited by: 2

Related to: 10